Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about enhanced adverse effects for instance drowsiness, although the scientific relevance is minimal in most clients – keep track of the affected individual for adverse effects (e.The objective of this analyze was